Gufic Biosciences informs about disclosure

26 Oct 2019 Evaluate

In continuation of its earlier letter dated 24th October, 2019, regarding the admission of petition by the National Company Law Tribunal (NCLT), Mumbai Bench, in order dated 22.10.2019 the certified copy of which was received by the Company on 23.10.2019, filed by one of the Operational Creditors, Scorpion Express (Scorpion), Gufic Biosciences has informed that the company and Scorpion have reached a settlement. The agreement of settlement has been signed on 25.10.2019 between both the parties and accordingly Scorpion will file an application for withdrawal of the petition before the NCLT. As the NCLT is on vacation, the said application for withdrawal shall be made after NCLT will resume, on or after 04.11.2019.

The above information is a part of company’s filings submitted to BSE.

Gufic Biosciences Share Price

403.15 -4.70 (-1.15%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.